Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola

Detalhes bibliográficos
Autor(a) principal: Sebastião, Cruz S.
Data de Publicação: 2022
Outros Autores: Cogle, Adis, Teixeira, Alice D’Alva, Cândido, Ana Micolo, Tchoni, Chissengo, Amorim, Maria João, Loureiro, N’gueza, Parimbelli, Paolo, Penha-Gonçalves, Carlos, Demengeot, Jocelyne, Sacomboio, Euclides, Mendes, Manuela, Arrais, Margarete, Morais, Joana, Vasconcelos, Jocelyne Neto de, Brito, Miguel
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.21/15132
Resumo: Background: Infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with clinical features of diverse severity. Few studies investigated the severity and mortality predictors of coronavirus disease 2019 (COVID-19) in Africa. Herein, we investigated the clinical features of severity and mortality among COVID-19 patients in Luanda, Angola. Methods: This multicenter cohort study involved 101 COVID-19 patients, between December 2020 and April 2021, with clinical and laboratory data collected. Analysis was done using independent-sample t-tests and Chi-square tests. The results were deemed significant when p < 0.05. Results: The mean age of patients was 51 years (ranging from 18 to 80 years) and 60.4% were male. Fever (46%), cough (47%), gastrointestinal symptoms (26.7%), and asthenia (26.7%), were the most common symptoms. About 64.4% of the patients presented coexistent disorders, including hypertension (42%), diabetes (17%), and chronic renal diseases (6%). About 23% were non-severe, 77% were severe, and 10% died during hospitalization. Variations in the concentration of neutrophil, urea, creatinine, c-reactive protein, sodium, creatine kinase, and chloride were independently associated with severity and/or mortality (p < 0.05). Conclusion: Several factors contributed to the severity and mortality among COVID-19 patients in Angola. Further studies related to clinical features should be carried out to help clinical decision-making and follow-up of COVID-19 patients in Angola.
id RCAP_b6e2b31455d85d482d5eb10d6e1a8e06
oai_identifier_str oai:repositorio.ipl.pt:10400.21/15132
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, AngolaCOVID-19SARS-CoV-2Clinical featuresMortalityAngolaLuandaBackground: Infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with clinical features of diverse severity. Few studies investigated the severity and mortality predictors of coronavirus disease 2019 (COVID-19) in Africa. Herein, we investigated the clinical features of severity and mortality among COVID-19 patients in Luanda, Angola. Methods: This multicenter cohort study involved 101 COVID-19 patients, between December 2020 and April 2021, with clinical and laboratory data collected. Analysis was done using independent-sample t-tests and Chi-square tests. The results were deemed significant when p < 0.05. Results: The mean age of patients was 51 years (ranging from 18 to 80 years) and 60.4% were male. Fever (46%), cough (47%), gastrointestinal symptoms (26.7%), and asthenia (26.7%), were the most common symptoms. About 64.4% of the patients presented coexistent disorders, including hypertension (42%), diabetes (17%), and chronic renal diseases (6%). About 23% were non-severe, 77% were severe, and 10% died during hospitalization. Variations in the concentration of neutrophil, urea, creatinine, c-reactive protein, sodium, creatine kinase, and chloride were independently associated with severity and/or mortality (p < 0.05). Conclusion: Several factors contributed to the severity and mortality among COVID-19 patients in Angola. Further studies related to clinical features should be carried out to help clinical decision-making and follow-up of COVID-19 patients in Angola.MDPIRCIPLSebastião, Cruz S.Cogle, AdisTeixeira, Alice D’AlvaCândido, Ana MicoloTchoni, ChissengoAmorim, Maria JoãoLoureiro, N’guezaParimbelli, PaoloPenha-Gonçalves, CarlosDemengeot, JocelyneSacomboio, EuclidesMendes, ManuelaArrais, MargareteMorais, JoanaVasconcelos, Jocelyne Neto deBrito, Miguel2022-12-07T16:55:09Z2022-102022-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.21/15132engSebastião CS, Cogle A, Teixeira AA, Cândido AM, Tchoni C, Brito M, et al. Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola. Trop Med Infect Dis. 2022;7(11):338.10.3390/tropicalmed7110338info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-08-03T10:12:17Zoai:repositorio.ipl.pt:10400.21/15132Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:22:51.379548Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola
title Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola
spellingShingle Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola
Sebastião, Cruz S.
COVID-19
SARS-CoV-2
Clinical features
Mortality
Angola
Luanda
title_short Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola
title_full Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola
title_fullStr Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola
title_full_unstemmed Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola
title_sort Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola
author Sebastião, Cruz S.
author_facet Sebastião, Cruz S.
Cogle, Adis
Teixeira, Alice D’Alva
Cândido, Ana Micolo
Tchoni, Chissengo
Amorim, Maria João
Loureiro, N’gueza
Parimbelli, Paolo
Penha-Gonçalves, Carlos
Demengeot, Jocelyne
Sacomboio, Euclides
Mendes, Manuela
Arrais, Margarete
Morais, Joana
Vasconcelos, Jocelyne Neto de
Brito, Miguel
author_role author
author2 Cogle, Adis
Teixeira, Alice D’Alva
Cândido, Ana Micolo
Tchoni, Chissengo
Amorim, Maria João
Loureiro, N’gueza
Parimbelli, Paolo
Penha-Gonçalves, Carlos
Demengeot, Jocelyne
Sacomboio, Euclides
Mendes, Manuela
Arrais, Margarete
Morais, Joana
Vasconcelos, Jocelyne Neto de
Brito, Miguel
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv RCIPL
dc.contributor.author.fl_str_mv Sebastião, Cruz S.
Cogle, Adis
Teixeira, Alice D’Alva
Cândido, Ana Micolo
Tchoni, Chissengo
Amorim, Maria João
Loureiro, N’gueza
Parimbelli, Paolo
Penha-Gonçalves, Carlos
Demengeot, Jocelyne
Sacomboio, Euclides
Mendes, Manuela
Arrais, Margarete
Morais, Joana
Vasconcelos, Jocelyne Neto de
Brito, Miguel
dc.subject.por.fl_str_mv COVID-19
SARS-CoV-2
Clinical features
Mortality
Angola
Luanda
topic COVID-19
SARS-CoV-2
Clinical features
Mortality
Angola
Luanda
description Background: Infection due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with clinical features of diverse severity. Few studies investigated the severity and mortality predictors of coronavirus disease 2019 (COVID-19) in Africa. Herein, we investigated the clinical features of severity and mortality among COVID-19 patients in Luanda, Angola. Methods: This multicenter cohort study involved 101 COVID-19 patients, between December 2020 and April 2021, with clinical and laboratory data collected. Analysis was done using independent-sample t-tests and Chi-square tests. The results were deemed significant when p < 0.05. Results: The mean age of patients was 51 years (ranging from 18 to 80 years) and 60.4% were male. Fever (46%), cough (47%), gastrointestinal symptoms (26.7%), and asthenia (26.7%), were the most common symptoms. About 64.4% of the patients presented coexistent disorders, including hypertension (42%), diabetes (17%), and chronic renal diseases (6%). About 23% were non-severe, 77% were severe, and 10% died during hospitalization. Variations in the concentration of neutrophil, urea, creatinine, c-reactive protein, sodium, creatine kinase, and chloride were independently associated with severity and/or mortality (p < 0.05). Conclusion: Several factors contributed to the severity and mortality among COVID-19 patients in Angola. Further studies related to clinical features should be carried out to help clinical decision-making and follow-up of COVID-19 patients in Angola.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-07T16:55:09Z
2022-10
2022-10-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.21/15132
url http://hdl.handle.net/10400.21/15132
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Sebastião CS, Cogle A, Teixeira AA, Cândido AM, Tchoni C, Brito M, et al. Clinical features related to severity and mortality among COVID-19 patients in a pre-vaccine period in Luanda, Angola. Trop Med Infect Dis. 2022;7(11):338.
10.3390/tropicalmed7110338
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133500588163072